Zhu YR - Search Results

1

Epigenetic regulation of alternative splicing.

Zhu LY, Zhu YR, Dai DJ, Wang X, Jin HC. Zhu LY, et al. Among authors: zhu yr. Am J Cancer Res. 2018 Dec 1;8(12):2346-2358. eCollection 2018. Am J Cancer Res. 2018. PMID: 30662796 Free PMC article. Review.

2

Exosome mediated multidrug resistance in cancer.

Yousafzai NA, Wang H, Wang Z, Zhu Y, Zhu L, Jin H, Wang X. Yousafzai NA, et al. Am J Cancer Res. 2018 Nov 1;8(11):2210-2226. eCollection 2018. Am J Cancer Res. 2018. PMID: 30555739 Free PMC article. Review.

3

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.

Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, Xu W, Jiang T, Feng L, Shin VY, Wang X, Jin H. Zhu L, et al. Cell Death Dis. 2019 May 16;10(6):383. doi: 10.1038/s41419-019-1585-2. Cell Death Dis. 2019. PMID: 31097692 Free PMC article.

4

EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer.

Yang L, Ying S, Hu S, Zhao X, Li M, Chen M, Zhu Y, Song P, Zhu L, Jiang T, An H, Yousafzai NA, Xu W, Zhang Z, Wang X, Feng L, Jin H. Yang L, et al. Signal Transduct Target Ther. 2019 Jul 12;4:25. doi: 10.1038/s41392-019-0059-4. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31637005 Free PMC article.

5

[No title available]

[No authors listed] [No authors listed] PMID: 32651361

6

Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition.

Han S, Zhu L, Zhu Y, Meng Y, Li J, Song P, Yousafzai NA, Feng L, Chen M, Wang Y, Jin H, Wang X. Han S, et al. Theranostics. 2021 Jul 25;11(17):8464-8479. doi: 10.7150/thno.60028. eCollection 2021. Theranostics. 2021. PMID: 34373753 Free PMC article.

7

Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B.

Zhou B, Zhu Y, Xu W, Zhou Q, Tan L, Zhu L, Chen H, Feng L, Hou T, Wang X, Chen D, Jin H. Zhou B, et al. Front Cell Dev Biol. 2021 Dec 17;9:741736. doi: 10.3389/fcell.2021.741736. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34977006 Free PMC article.

8

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.

Zhu Y, Zhou B, Hu X, Ying S, Zhou Q, Xu W, Feng L, Hou T, Wang X, Zhu L, Jin H. Zhu Y, et al. Clin Transl Med. 2022 Jan;12(1):e703. doi: 10.1002/ctm2.703. Clin Transl Med. 2022. PMID: 35073459 Free PMC article.

9

Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma.

Chen M, Wang W, Hu S, Tong Y, Li Y, Wei Q, Yu L, Zhu L, Zhu Y, Liu L, Ju Z, Wang X, Jin H, Feng L. Chen M, et al. Cell Commun Signal. 2022 Mar 28;20(1):39. doi: 10.1186/s12964-022-00850-2. Cell Commun Signal. 2022. PMID: 35346236 Free PMC article.

10

RNA-based therapeutics: an overview and prospectus.

Zhu Y, Zhu L, Wang X, Jin H. Zhu Y, et al. Cell Death Dis. 2022 Jul 23;13(7):644. doi: 10.1038/s41419-022-05075-2. Cell Death Dis. 2022. PMID: 35871216 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page